ArticleEJHaem2026

Immune Effector Cell-Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene-Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell Boosting.

Keishi Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.